Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada

IMPORTANCE: Approximately 1 in 7 patients with metastatic breast cancer (MBC) will receive radiotherapy for brain metastases (BRM). Significant differences in cumulative incidence of BRM by breast cancer subtype may inform future BRM screening protocols. OBJECTIVE: To describe cumulative incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin Ye, Rosen, Michael N., Chehade, Rania, Sahgal, Arjun, Das, Sunit, Warner, Ellen, Saskin, Refik, Zhang, Bo, Soliman, Hany, Chan, Kelvin K. W., Jerzak, Katarzyna J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375172/
https://www.ncbi.nlm.nih.gov/pubmed/35960523
http://dx.doi.org/10.1001/jamanetworkopen.2022.25424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375172/
https://www.ncbi.nlm.nih.gov/pubmed/35960523
http://dx.doi.org/10.1001/jamanetworkopen.2022.25424

Ejemplares similares